These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26716385)

  • 1. Downregulation of TRAP1 sensitizes glioblastoma cells to temozolomide chemotherapy through regulating metabolic reprogramming.
    Wu J; Liu Y; Cho K; Dong X; Teng L; Han D; Liu H; Chen X; Chen X; Hou X; Peng F; Bi Y; Shen C; Zhao S
    Neuroreport; 2016 Feb; 27(3):136-44. PubMed ID: 26716385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3 is essential for the maintenance of neurosphere-initiating tumor cells in patients with glioblastomas: a potential for targeted therapy?
    Villalva C; Martin-Lannerée S; Cortes U; Dkhissi F; Wager M; Le Corf A; Tourani JM; Dusanter-Fourt I; Turhan AG; Karayan-Tapon L
    Int J Cancer; 2011 Feb; 128(4):826-38. PubMed ID: 20473906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of temozolomide antitumor effect by purine receptor ligands able to restrain the in vitro growth of human glioblastoma stem cells.
    D'Alimonte I; Nargi E; Zuccarini M; Lanuti P; Di Iorio P; Giuliani P; Ricci-Vitiani L; Pallini R; Caciagli F; Ciccarelli R
    Purinergic Signal; 2015 Sep; 11(3):331-46. PubMed ID: 25976165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat Shock Factor 1 Depletion Sensitizes A172 Glioblastoma Cells to Temozolomide via Suppression of Cancer Stem Cell-Like Properties.
    Im CN; Yun HH; Lee JH
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
    Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
    Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dedifferentiation of patient-derived glioblastoma multiforme cell lines results in a cancer stem cell-like state with mitogen-independent growth.
    Olmez I; Shen W; McDonald H; Ozpolat B
    J Cell Mol Med; 2015 Jun; 19(6):1262-72. PubMed ID: 25787115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MELK-dependent FOXM1 phosphorylation is essential for proliferation of glioma stem cells.
    Joshi K; Banasavadi-Siddegowda Y; Mo X; Kim SH; Mao P; Kig C; Nardini D; Sobol RW; Chow LM; Kornblum HI; Waclaw R; Beullens M; Nakano I
    Stem Cells; 2013 Jun; 31(6):1051-63. PubMed ID: 23404835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
    Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
    Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temozolomide downregulates P-glycoprotein expression in glioblastoma stem cells by interfering with the Wnt3a/glycogen synthase-3 kinase/β-catenin pathway.
    Riganti C; Salaroglio IC; Caldera V; Campia I; Kopecka J; Mellai M; Annovazzi L; Bosia A; Ghigo D; Schiffer D
    Neuro Oncol; 2013 Nov; 15(11):1502-17. PubMed ID: 23897632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line.
    Montaldi AP; Godoy PR; Sakamoto-Hojo ET
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():19-29. PubMed ID: 26520369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HMGA1 silencing reduces stemness and temozolomide resistance in glioblastoma stem cells.
    Colamaio M; Tosti N; Puca F; Mari A; Gattordo R; Kuzay Y; Federico A; Pepe A; Sarnataro D; Ragozzino E; Raia M; Hirata H; Gemei M; Mimori K; Del Vecchio L; Battista S; Fusco A
    Expert Opin Ther Targets; 2016 Oct; 20(10):1169-79. PubMed ID: 27486901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide.
    Yan T; Skaftnesmo KO; Leiss L; Sleire L; Wang J; Li X; Enger PØ
    BMC Cancer; 2011 Dec; 11():524. PubMed ID: 22185371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress stimuli induce cancer-stemness gene expression via Sp1 activation leading to therapeutic resistance in glioblastoma.
    Chang KY; Huang CT; Hsu TI; Hsu CC; Liu JJ; Chuang CK; Hung JJ; Chang WC; Tsai KK; Chuang JY
    Biochem Biophys Res Commun; 2017 Nov; 493(1):14-19. PubMed ID: 28939040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JNK contributes to temozolomide resistance of stem-like glioblastoma cells via regulation of MGMT expression.
    Okada M; Sato A; Shibuya K; Watanabe E; Seino S; Suzuki S; Seino M; Narita Y; Shibui S; Kayama T; Kitanaka C
    Int J Oncol; 2014 Feb; 44(2):591-9. PubMed ID: 24316756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressing H19 Modulates Tumorigenicity and Stemness in U251 and U87MG Glioma Cells.
    Li W; Jiang P; Sun X; Xu S; Ma X; Zhan R
    Cell Mol Neurobiol; 2016 Nov; 36(8):1219-1227. PubMed ID: 26983719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic trioxide depletes cancer stem-like cells and inhibits repopulation of neurosphere derived from glioblastoma by downregulation of Notch pathway.
    Wu J; Ji Z; Liu H; Liu Y; Han D; Shi C; Shi C; Wang C; Yang G; Chen X; Shen C; Li H; Bi Y; Zhang D; Zhao S
    Toxicol Lett; 2013 Jun; 220(1):61-9. PubMed ID: 23542114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAZ promotes temozolomide resistance by upregulating MCL-1 in human glioma cells.
    Tian T; Li A; Lu H; Luo R; Zhang M; Li Z
    Biochem Biophys Res Commun; 2015 Aug; 463(4):638-43. PubMed ID: 26043698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between TRAP1 and Sirtuin-3 Modulates Mitochondrial Respiration and Oxidative Stress to Maintain Stemness of Glioma Stem Cells.
    Park HK; Hong JH; Oh YT; Kim SS; Yin J; Lee AJ; Chae YC; Kim JH; Park SH; Park CK; Park MJ; Park JB; Kang BH
    Cancer Res; 2019 Apr; 79(7):1369-1382. PubMed ID: 30683653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversing glioma malignancy: a new look at the role of antidepressant drugs as adjuvant therapy for glioblastoma multiforme.
    Bielecka-Wajdman AM; Lesiak M; Ludyga T; Sieroń A; Obuchowicz E
    Cancer Chemother Pharmacol; 2017 Jun; 79(6):1249-1256. PubMed ID: 28500556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide.
    Cominelli M; Grisanti S; Mazzoleni S; Branca C; Buttolo L; Furlan D; Liserre B; Bonetti MF; Medicina D; Pellegrini V; Buglione M; Liserre R; Pellegatta S; Finocchiaro G; Dalerba P; Facchetti F; Pizzi M; Galli R; Poliani PL
    J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25739547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.